Figure 2. Time to Recurrence of Bladder Cancer.

A, Cumulative incidence of recurrence in the primary analysis by randomized treatment group. All randomized patients who met eligibility criteria were included. B, Cumulative incidence of recurrence by randomized treatment group among patients who were found to have low-grade non–muscle-invasive urothelial cancer at transurethral resection of bladder tumor and received instillation as randomized.